Clinical Trial Update: A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma [Phase 1]

View source ↗

Summary

This clinical trial investigates temozolomide (Temodar) in combination with the HDAC inhibitor Abexinostat for recurrent high-grade gliomas, including glioblast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma
• Gliosarcoma
• High-grade Glioma

Drugs mentioned

• Abexinostat (Abexinostat)
• Temodar (Temozolomide)

Snippet

Sponsor: University of Nebraska | Conditions: Recurrent High Grade Glioma, Anaplastic Astrocytoma | Phase 1 | Status: RECRUITING